CJC-1295 (No DAC)
Research Grade
$95
$95.00
1 × $95.00 pick 2 and save $9.50
Buy More Save More
Same day dispatch · free express shipping over $250
Certificates of Analysis
All certificates →Current batch · on shelf
98.97%
Purity by HPLC · identity confirmed by MS
20 August 2026
- Batch
- APL-CJC10-2608-03
- Net content
- 10.12 mg
- Specification
- ≥98.0% purity · passes
Every batch is analysed in-house by HPLC and mass spectrometry and ships with a batch-specific Certificate of Analysis. Independent third-party verification is added to select batches; none is published for CJC-1295 (No DAC) yet.
Molecular Details
Every batch is analysed in-house by HPLC & mass spectrometry and ships with a Certificate of Analysis; select batches are additionally verified by an independent third-party laboratory.
Usage & Storage
Description
DPP-4-resistant 29 amino acid GHRH analogue without DAC. Short ~30 minute half-life, studied in pulsatile growth hormone release research.
- 29 amino acid GHRH analogue (Modified GRF 1-29)
- D-Ala2, Gln8, Ala15, Leu27 substitutions resist DPP-4 cleavage
- No DAC — short ~30 minute plasma half-life
- Studied in pulsatile GH-release research models
- Research Grade purity >=98%
CJC-1295 without DAC — also known as Modified GRF (1-29) or Mod GRF — is a 29 amino acid analogue of endogenous growth hormone releasing hormone (GHRH), carrying four amino acid substitutions (D-Ala2, Gln8, Ala15, Leu27) that confer resistance to dipeptidyl peptidase-4 (DPP-4) cleavage and improve plasma stability relative to native GHRH(1-29). Because it omits the Drug Affinity Complex (DAC) — the maleimidopropionyl linker that binds covalently to serum albumin in the DAC variant — it retains a short plasma half-life of roughly 30 minutes. This makes it the form studied in models of discrete, pulsatile growth hormone release rather than sustained elevation, more closely mimicking the endogenous secretory rhythm. Research has characterised its binding at the GHRH receptor on anterior pituitary somatotrophs and the resulting G-protein coupled cascade through adenylyl cyclase, cAMP and protein kinase A. It is frequently studied in combination with GHRP-class secretagogues, which act through an entirely independent receptor system. Supplied as a lyophilised white powder with a molecular weight of approximately 3367 Da and molecular formula C152H252N44O42. Supplied strictly for in-vitro laboratory research. Not for human or veterinary consumption.
Frequently Asked Questions
Is CJC-1295 (No DAC) legal to buy in Australia?
CJC-1295 (No DAC) is supplied strictly as a research chemical for in-vitro laboratory use. It is not approved for human therapeutic use in Australia and is not for human or animal consumption. Researchers are responsible for compliance with Therapeutic Goods Administration (TGA) regulations and their institution's protocols.
What purity is CJC-1295 (No DAC)?
We specify ≥98% purity — the High-Tier Research Grade (commercial RUO) standard. Every batch is analysed in-house by HPLC and mass spectrometry and ships with a Certificate of Analysis; select batches also undergo independent, third-party purity verification.
Does CJC-1295 (No DAC) ship with a Certificate of Analysis (COA)?
Yes — every batch ships with a batch-specific COA documenting HPLC purity and mass-spectrometry identity. 3 CJC-1295 (No DAC) batch certificates are published in full at australianpeptidelabs.com.au/certificates/cjc-1295, so the analysis can be read before ordering and the batch number printed on the vial matched against it.
Where can I buy CJC-1295 (No DAC) in Australia?
CJC-1295 (No DAC) can be ordered here from Australian Peptide Labs for in-vitro research use, dispatched same day from within Australia with a COA included.
Do you provide dosing or administration guidance for CJC-1295 (No DAC)?
No. As these compounds are supplied for laboratory research only, we do not provide dosing or administration protocols. Our research library covers reconstitution and concentration calculations for in-vitro work.